Which has stronger earnings & valuation, TRNS or INTT?

inTEST has lower revenue, but higher earnings than Transcat. Transcat is trading at a lower price-to-earnings ratio than inTEST, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Transcat $331.88M 2.51 $5.38M $0.58 153.50 inTEST $121.07M 1.63 $9.34M $0.04 392.50

Is TRNS or INTT more profitable?

inTEST has a net margin of 2.33% compared to Transcat's net margin of 1.62%. Transcat's return on equity of 5.84% beat inTEST's return on equity. Company Net Margins Return on Equity Return on Assets Transcat 1.62% 5.84% 3.78% inTEST 2.33% 5.31% 3.42%

Does the media favor FEIM or INTT?

In the previous week, Frequency Electronics had 2 more articles in the media than inTEST. MarketBeat recorded 3 mentions for Frequency Electronics and 1 mentions for inTEST. inTEST's average media sentiment score of 0.34 beat Frequency Electronics' score of 0.00 indicating that inTEST is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Frequency Electronics 0 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral inTEST 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Is CTKB or INTT more profitable?

inTEST has a net margin of 2.33% compared to Cytek Biosciences' net margin of -36.25%. inTEST's return on equity of 5.31% beat Cytek Biosciences' return on equity. Company Net Margins Return on Equity Return on Assets Cytek Biosciences -36.25% -10.07% -7.56% inTEST 2.33% 5.31% 3.42%

Do analysts recommend INTT or OPTX?

inTEST currently has a consensus price target of $19.00, indicating a potential upside of 21.02%. Given inTEST's stronger consensus rating and higher possible upside, equities research analysts clearly believe inTEST is more favorable than Syntec Optics. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score inTEST 0 Sell rating(s) 1 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.50 Syntec Optics 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00

Which has better valuation & earnings, INTT or OPTX?

inTEST has higher revenue and earnings than Syntec Optics. Syntec Optics is trading at a lower price-to-earnings ratio than inTEST, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio inTEST $121.07M 1.63 $9.34M $0.04 392.50 Syntec Optics $28.08M 15.61 -$1.79M -$0.08 N/A

Is INTT or OPTX more profitable?

inTEST has a net margin of 2.33% compared to Syntec Optics' net margin of -10.95%. inTEST's return on equity of 5.31% beat Syntec Optics' return on equity. Company Net Margins Return on Equity Return on Assets inTEST 2.33% 5.31% 3.42% Syntec Optics -10.95% -30.86% -12.35%

Does the media favor INTT or OPTX?

In the previous week, Syntec Optics had 1 more articles in the media than inTEST. MarketBeat recorded 2 mentions for Syntec Optics and 1 mentions for inTEST. Syntec Optics' average media sentiment score of 1.00 beat inTEST's score of 0.34 indicating that Syntec Optics is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment inTEST 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Syntec Optics 1 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher earnings & valuation, INTT or MASS?

908 Devices has lower revenue, but higher earnings than inTEST. 908 Devices is trading at a lower price-to-earnings ratio than inTEST, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio inTEST $121.07M 1.63 $9.34M $0.04 392.50 908 Devices $56.20M 5.85 $19.49M -$1.00 N/A

Is INTT or MASS more profitable?

inTEST has a net margin of 2.33% compared to 908 Devices' net margin of -62.40%. inTEST's return on equity of 5.31% beat 908 Devices' return on equity. Company Net Margins Return on Equity Return on Assets inTEST 2.33% 5.31% 3.42% 908 Devices -62.40% -14.03% -10.40%

inTEST (INTT) Competitors

$15.70 0.00 (0.00%)

Closing price 07/2/2026 04:00 PM Eastern

Extended Trading

$16.04 +0.34 (+2.13%)

As of 07/2/2026 07:52 PM Eastern

Compare

INTT vs. TRNS, FEIM, CTKB, OPTX, and MASS

Should you buy inTEST stock or one of its competitors? MarketBeat compares inTEST with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with inTEST include Transcat (TRNS), Frequency Electronics (FEIM), Cytek Biosciences (CTKB), Syntec Optics (OPTX), and 908 Devices (MASS). These companies are all part of the "measuring and control equipment" industry.

How does inTEST compare to Transcat?

Transcat (NASDAQ:TRNS) and inTEST (NYSE:INTT) are both small-cap computer and technology companies, but which is the better stock? We will compare the two businesses based on the strength of their dividends, earnings, profitability, institutional ownership, risk, valuation, media sentiment and analyst recommendations.

Transcat has a beta of 0.69, meaning that its stock price is 31% less volatile than the broader market. Comparatively, inTEST has a beta of 1.47, meaning that its stock price is 47% more volatile than the broader market.

inTEST has a net margin of 2.33% compared to Transcat's net margin of 1.62%. Transcat's return on equity of 5.84% beat inTEST's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Transcat	1.62%	5.84%	3.78%
inTEST	2.33%	5.31%	3.42%

inTEST has lower revenue, but higher earnings than Transcat. Transcat is trading at a lower price-to-earnings ratio than inTEST, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Transcat	$331.88M	2.51	$5.38M	$0.58	153.50
inTEST	$121.07M	1.63	$9.34M	$0.04	392.50

Transcat presently has a consensus price target of $105.33, suggesting a potential upside of 18.31%. inTEST has a consensus price target of $19.00, suggesting a potential upside of 21.02%. Given inTEST's higher possible upside, analysts clearly believe inTEST is more favorable than Transcat.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Transcat	1 Sell rating(s)	1 Hold rating(s)	2 Buy rating(s)	1 Strong Buy rating(s)	2.60
inTEST	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

98.3% of Transcat shares are held by institutional investors. Comparatively, 63.2% of inTEST shares are held by institutional investors. 2.8% of Transcat shares are held by insiders. Comparatively, 5.2% of inTEST shares are held by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company is poised for long-term growth.

In the previous week, inTEST had 1 more articles in the media than Transcat. MarketBeat recorded 1 mentions for inTEST and 0 mentions for Transcat. inTEST's average media sentiment score of 0.34 beat Transcat's score of 0.00 indicating that inTEST is being referred to more favorably in the news media.

Company	Overall Sentiment
Transcat	Neutral
inTEST	Neutral

Summary

Transcat beats inTEST on 10 of the 17 factors compared between the two stocks.

How does inTEST compare to Frequency Electronics?

Frequency Electronics (NASDAQ:FEIM) and inTEST (NYSE:INTT) are both small-cap computer and technology companies, but which is the superior stock? We will compare the two companies based on the strength of their valuation, media sentiment, profitability, dividends, analyst recommendations, institutional ownership, earnings and risk.

Frequency Electronics has higher earnings, but lower revenue than inTEST. Frequency Electronics is trading at a lower price-to-earnings ratio than inTEST, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Frequency Electronics	$69.81M	9.10	$23.69M	$0.75	86.12
inTEST	$121.07M	1.63	$9.34M	$0.04	392.50

Frequency Electronics currently has a consensus price target of $43.67, suggesting a potential downside of 32.39%. inTEST has a consensus price target of $19.00, suggesting a potential upside of 21.02%. Given inTEST's higher probable upside, analysts clearly believe inTEST is more favorable than Frequency Electronics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Frequency Electronics	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	1 Strong Buy rating(s)	3.00
inTEST	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

Frequency Electronics has a net margin of 10.78% compared to inTEST's net margin of 2.33%. Frequency Electronics' return on equity of 12.69% beat inTEST's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Frequency Electronics	10.78%	12.69%	7.84%
inTEST	2.33%	5.31%	3.42%

In the previous week, Frequency Electronics had 2 more articles in the media than inTEST. MarketBeat recorded 3 mentions for Frequency Electronics and 1 mentions for inTEST. inTEST's average media sentiment score of 0.34 beat Frequency Electronics' score of 0.00 indicating that inTEST is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Frequency Electronics	0 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
inTEST	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

58.6% of Frequency Electronics shares are owned by institutional investors. Comparatively, 63.2% of inTEST shares are owned by institutional investors. 28.0% of Frequency Electronics shares are owned by company insiders. Comparatively, 5.2% of inTEST shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Frequency Electronics has a beta of 0.71, suggesting that its stock price is 29% less volatile than the broader market. Comparatively, inTEST has a beta of 1.47, suggesting that its stock price is 47% more volatile than the broader market.

Summary

Frequency Electronics beats inTEST on 11 of the 16 factors compared between the two stocks.

How does inTEST compare to Cytek Biosciences?

Cytek Biosciences (NASDAQ:CTKB) and inTEST (NYSE:INTT) are both small-cap measuring and control equipment companies, but which is the superior stock? We will contrast the two businesses based on the strength of their risk, institutional ownership, dividends, profitability, media sentiment, analyst recommendations, earnings and valuation.

Cytek Biosciences presently has a consensus price target of $5.69, indicating a potential upside of 23.91%. inTEST has a consensus price target of $19.00, indicating a potential upside of 21.02%. Given Cytek Biosciences' higher probable upside, equities analysts plainly believe Cytek Biosciences is more favorable than inTEST.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Cytek Biosciences	1 Sell rating(s)	2 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.33
inTEST	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50

inTEST has a net margin of 2.33% compared to Cytek Biosciences' net margin of -36.25%. inTEST's return on equity of 5.31% beat Cytek Biosciences' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Cytek Biosciences	-36.25%	-10.07%	-7.56%
inTEST	2.33%	5.31%	3.42%

inTEST has lower revenue, but higher earnings than Cytek Biosciences. Cytek Biosciences is trading at a lower price-to-earnings ratio than inTEST, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Cytek Biosciences	$201.49M	2.94	-$66.54M	-$0.57	N/A
inTEST	$121.07M	1.63	$9.34M	$0.04	392.50

69.5% of Cytek Biosciences shares are owned by institutional investors. Comparatively, 63.2% of inTEST shares are owned by institutional investors. 10.4% of Cytek Biosciences shares are owned by insiders. Comparatively, 5.2% of inTEST shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

Cytek Biosciences has a beta of 1.17, meaning that its stock price is 17% more volatile than the broader market. Comparatively, inTEST has a beta of 1.47, meaning that its stock price is 47% more volatile than the broader market.

In the previous week, inTEST had 1 more articles in the media than Cytek Biosciences. MarketBeat recorded 1 mentions for inTEST and 0 mentions for Cytek Biosciences. inTEST's average media sentiment score of 0.34 beat Cytek Biosciences' score of 0.00 indicating that inTEST is being referred to more favorably in the news media.

Company	Overall Sentiment
Cytek Biosciences	Neutral
inTEST	Neutral

Summary

inTEST beats Cytek Biosciences on 10 of the 16 factors compared between the two stocks.

How does inTEST compare to Syntec Optics?

inTEST (NYSE:INTT) and Syntec Optics (NASDAQ:OPTX) are both small-cap measuring and control equipment companies, but which is the superior investment? We will compare the two businesses based on the strength of their institutional ownership, dividends, risk, valuation, analyst recommendations, profitability, media sentiment and earnings.

63.2% of inTEST shares are owned by institutional investors. 5.2% of inTEST shares are owned by company insiders. Comparatively, 0.8% of Syntec Optics shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

inTEST currently has a consensus price target of $19.00, indicating a potential upside of 21.02%. Given inTEST's stronger consensus rating and higher possible upside, equities research analysts clearly believe inTEST is more favorable than Syntec Optics.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
inTEST	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
Syntec Optics	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00

inTEST has higher revenue and earnings than Syntec Optics. Syntec Optics is trading at a lower price-to-earnings ratio than inTEST, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
inTEST	$121.07M	1.63	$9.34M	$0.04	392.50
Syntec Optics	$28.08M	15.61	-$1.79M	-$0.08	N/A

inTEST has a beta of 1.47, indicating that its share price is 47% more volatile than the broader market. Comparatively, Syntec Optics has a beta of -0.86, indicating that its share price is 186% less volatile than the broader market.

inTEST has a net margin of 2.33% compared to Syntec Optics' net margin of -10.95%. inTEST's return on equity of 5.31% beat Syntec Optics' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
inTEST	2.33%	5.31%	3.42%
Syntec Optics	-10.95%	-30.86%	-12.35%

In the previous week, Syntec Optics had 1 more articles in the media than inTEST. MarketBeat recorded 2 mentions for Syntec Optics and 1 mentions for inTEST. Syntec Optics' average media sentiment score of 1.00 beat inTEST's score of 0.34 indicating that Syntec Optics is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
inTEST	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Syntec Optics	1 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

inTEST beats Syntec Optics on 13 of the 16 factors compared between the two stocks.

How does inTEST compare to 908 Devices?

inTEST (NYSE:INTT) and 908 Devices (NASDAQ:MASS) are both small-cap measuring and control equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their risk, valuation, profitability, media sentiment, earnings, dividends, analyst recommendations and institutional ownership.

In the previous week, inTEST had 1 more articles in the media than 908 Devices. MarketBeat recorded 1 mentions for inTEST and 0 mentions for 908 Devices. 908 Devices' average media sentiment score of 0.63 beat inTEST's score of 0.34 indicating that 908 Devices is being referred to more favorably in the news media.

Company	Overall Sentiment
inTEST	Neutral
908 Devices	Positive

63.2% of inTEST shares are owned by institutional investors. Comparatively, 88.1% of 908 Devices shares are owned by institutional investors. 5.2% of inTEST shares are owned by insiders. Comparatively, 28.2% of 908 Devices shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

inTEST has a net margin of 2.33% compared to 908 Devices' net margin of -62.40%. inTEST's return on equity of 5.31% beat 908 Devices' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
inTEST	2.33%	5.31%	3.42%
908 Devices	-62.40%	-14.03%	-10.40%

inTEST presently has a consensus price target of $19.00, suggesting a potential upside of 21.02%. 908 Devices has a consensus price target of $12.00, suggesting a potential upside of 38.09%. Given 908 Devices' higher possible upside, analysts plainly believe 908 Devices is more favorable than inTEST.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
inTEST	0 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.50
908 Devices	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

inTEST has a beta of 1.47, meaning that its share price is 47% more volatile than the broader market. Comparatively, 908 Devices has a beta of 0.63, meaning that its share price is 37% less volatile than the broader market.

908 Devices has lower revenue, but higher earnings than inTEST. 908 Devices is trading at a lower price-to-earnings ratio than inTEST, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
inTEST	$121.07M	1.63	$9.34M	$0.04	392.50
908 Devices	$56.20M	5.85	$19.49M	-$1.00	N/A

Summary

inTEST beats 908 Devices on 9 of the 15 factors compared between the two stocks.

Get inTEST News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding INTT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

INTT vs. The Competition

Export

Metric	inTEST	Instruments to measure electricity Industry	Computer Sector	NYSE Exchange
Market Cap	$197.27M	$98.67M	$38.45B	$23.54B
Dividend Yield	N/A	N/A	3.17%	3.98%
P/E Ratio	68.26	68.26	78.86	31.55
Price / Sales	1.63	0.82	602.41	21.71
Price / Cash	5.75	5.75	45.62	25.36
Price / Book	1.98	1.98	9.55	4.81
Net Income	$9.34M	-$2.88M	$1.07B	$1.07B
7 Day Performance	-5.54%	-5.54%	0.97%	0.56%
1 Month Performance	7.02%	7.02%	0.23%	4.54%
1 Year Performance	119.89%	119.89%	143.56%	18.23%

inTEST Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
INTT inTEST	1.7456 of 5 stars	$15.70 flat	$19.00 +21.0%	+119.9%	$197.27M	$121.07M	68.26	320	Gap Up
TRNS Transcat	3.1247 of 5 stars	$92.77 +1.6%	$105.33 +13.5%	-0.9%	$852.62M	$331.88M	159.95	1,413	Gap Up
FEIM Frequency Electronics	0.4841 of 5 stars	$66.35 +7.4%	$43.67 -34.2%	+196.3%	$607.94M	$69.81M	88.47	200	News Coverage Positive News Upcoming Earnings Analyst Upgrade
CTKB Cytek Biosciences	2.5055 of 5 stars	$4.43 +2.1%	$5.69 +28.4%	+22.1%	$560.48M	$201.49M	N/A	500	Positive News
OPTX Syntec Optics	0.2944 of 5 stars	$12.45 +17.7%	N/A	+691.3%	$426.16M	$28.08M	N/A	3	Positive News

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NYSE:INTT) was last updated on 7/5/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

inTEST (INTT) Competitors

INTT vs. TRNS, FEIM, CTKB, OPTX, and MASS

How does inTEST compare to Transcat?

Summary

How does inTEST compare to Frequency Electronics?

Summary

How does inTEST compare to Cytek Biosciences?

Summary

How does inTEST compare to Syntec Optics?

Summary

How does inTEST compare to 908 Devices?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INTT vs. The Competition

inTEST Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

inTEST (INTT) Competitors

INTT vs. TRNS, FEIM, CTKB, OPTX, and MASS

How does inTEST compare to Transcat?

Which has more volatility & risk, TRNS or INTT?

Is TRNS or INTT more profitable?

Which has stronger earnings & valuation, TRNS or INTT?

Do analysts prefer TRNS or INTT?

Do insiders and institutionals have more ownership in TRNS or INTT?

Does the media favor TRNS or INTT?

Summary

How does inTEST compare to Frequency Electronics?

Which has preferable earnings and valuation, FEIM or INTT?

Do analysts recommend FEIM or INTT?

Is FEIM or INTT more profitable?

Does the media favor FEIM or INTT?

Do institutionals & insiders have more ownership in FEIM or INTT?

Which has more volatility & risk, FEIM or INTT?

Summary

How does inTEST compare to Cytek Biosciences?

Do analysts prefer CTKB or INTT?

Is CTKB or INTT more profitable?

Which has stronger valuation & earnings, CTKB or INTT?

Do institutionals & insiders believe in CTKB or INTT?

Which has more risk & volatility, CTKB or INTT?

Does the media prefer CTKB or INTT?

Summary

How does inTEST compare to Syntec Optics?

Do institutionals & insiders have more ownership in INTT or OPTX?

Do analysts recommend INTT or OPTX?

Which has better valuation & earnings, INTT or OPTX?

Which has more volatility & risk, INTT or OPTX?

Is INTT or OPTX more profitable?

Does the media favor INTT or OPTX?

Summary

How does inTEST compare to 908 Devices?

Does the media refer more to INTT or MASS?

Do insiders and institutionals hold more shares of INTT or MASS?

Is INTT or MASS more profitable?

Do analysts prefer INTT or MASS?

Which has more risk & volatility, INTT or MASS?

Which has higher earnings & valuation, INTT or MASS?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

INTT vs. The Competition

inTEST Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools